Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

ASH preview – waiting for Editas
EP Vantage
Wed, 11/9/22 - 10:40 am
Tags:
ASH 2022, sickle cell disease, Bluebird Bio, Sangamo BioSciences, Novartis, Editas Medicine, gene therapy, Vertex Pharmaceuticals, Sanofi
Cost watchdog ICER backs multimillion-dollar price tags for BioMarin, CSL hemophilia gene therapies
Fierce Pharma
Thu, 11/3/22 - 11:02 am
Tags:
ICER, drug pricing, gene therapy, Biomarin, CSL, Bluebird Bio, hemophilia
Bluebird wins FDA approval of gene therapy for rare brain disorder
BioPharma Dive
Sun, 09/18/22 - 10:23 pm
Tags:
Bluebird Bio, gene therapy, cALD, Skysona, FDA
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
Tags:
FDA, Bristol Myers Squibb, deucravacitinib, Amylyx Pharmaceuticals, ALS, AMX0035, Ferring Pharmaceuticals, microbiome, RBX2660, Revance Therapeutics, Bluebird Bio, Spectrum Pharmaceuticals, JNJ, Oncopeptides
bluebird bio Scores First U.S. Approval for Lentiviral Vector Gene Therapy
BioSpace
Wed, 08/17/22 - 11:34 pm
Tags:
Bluebird Bio, FDA, gene therapy, beta thalassemia, Zynteglo, beti-cel
Go or no go? J&J’s bispecific FDA first
EP Vantage
Thu, 07/28/22 - 11:04 am
Tags:
JNJ, Amicus Therapeutics, Acadia Pharma, Bluebird Bio, FDA
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
Tags:
FDA, drug approvals, Amicus, Bluebird Bio, Bristol Myers Squibb, Eli Lilly, Marinus Pharma, Amylyx, Novartis
bluebird bio Soars as FDA Adcom Recommends Second Gene Therapy
BioSpace
Sun, 06/12/22 - 08:30 pm
Tags:
Bluebird Bio, FDA, lentiviral vectors, beti-cel
FDA panel backs Bluebird gene therapy despite safety risks
BioPharma Dive
Fri, 06/10/22 - 10:56 am
Tags:
Bluebird Bio, FDA, eli-cel, cALD
Bluebird bio’s future in balance as FDA weighs gene therapy approvals
BioPharma Dive
Thu, 06/9/22 - 10:32 am
Tags:
Bluebird Bio, gene therapy
bluebird bio Blazes Trail for Lentiviral Vectors at Upcoming FDA Meeting
BioSpace
Tue, 06/7/22 - 11:57 pm
Tags:
Bluebird Bio, lentiviral vectors, FDA, cell therapy
Ahead of 2-day adcomm, FDA sounds positive on one bluebird gene therapy but questions remain for another
Endpoints
Tue, 06/7/22 - 10:08 am
Tags:
FDA, Bluebird Bio, gene therapy, eli-cel, beti-cel
Even at $2M+, ICER calls bluebird's potential gene therapy for blood disorder 'superior' to standard of care
Endpoints
Thu, 06/2/22 - 10:22 am
Tags:
Bluebird Bio, ICER, gene therapy, FDA, beti-cel
Go or no go? The FDA’s Amylyx dilemma
EP Vantage
Tue, 05/31/22 - 10:29 am
Tags:
FDA, Amylyx, AMX0035, ALS, COVID-19, vaccines, Novavax, Moderna Therapeutics, Pfizer, Acadia Pharma, Bluebird Bio
Roche and bluebird bio settle year-long trademark case, but keep quiet on the details
Endpoints
Thu, 05/19/22 - 08:59 pm
Tags:
Bluebird Bio, Roche, Spark Therapeutics, trademark, legal
ICER says bluebird bio’s $2.1m gene therapy is cost-effective
Pharmaforum
Thu, 04/14/22 - 10:36 am
Tags:
Bluebird Bio, ICER, beti-cel, FDA
Feeling Blue: bluebird bio cuts staff by 30%, prepares for FDA decision
BioSpace
Tue, 04/5/22 - 11:55 am
Tags:
Bluebird Bio, FDA, layoffs, restructuring, eli-cel, beti-cel
As biotech retreats, gene therapy companies retrench and redraw plans
BioPharma Dive
Thu, 03/24/22 - 08:29 pm
Tags:
biotech, gene therapy, layoffs, R&D, Bluebird Bio, Allogene, uniQure
2seventy bio's honeymoon phase is over as job cuts hit 6% of staff
Fierce Biotech
Wed, 03/23/22 - 11:10 am
Tags:
2seventy bio, layoffs, Bluebird Bio
bluebird says future uncertain as delays to gene therapies bite
Pharmaforum
Sun, 03/6/22 - 11:18 pm
Tags:
Bluebird Bio, gene therapy, beti-cel, eli-cel, lovo-cel

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.